Miss Melissa Lynn Cunningham-ingram, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1255 Bell Run Rd, Fairmont, WV 26554 Phone: 304-695-4901 |
News Archive
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
Kaiser Health News staff writers Phil Galewitz and Andrew Villegas write that while Democrats have said that the new health law "would immediately stop insurers from denying coverage to children with pre-existing medical conditions, ... health advocates and some insurers say the law does not clearly state that such protection starts this year.
A rare autoimmune disease creates sudden pain in the abdomen or the head, sending a patient to the emergency room with a potentially fatal condition. The pain comes from a multitude of blockages of tiny blood vessels, formed after the patient's own immune system somehow inhibits an enzyme that is vital to control clotting.
Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.
› Verified 2 days ago